NDI warning letters fuel criticism of FDA enforcement approach On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Is BPC 157 Banned? Oral vs. Injectable Forms Explained
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda warning letter bpc-157 dietary supplement FDA to weigh easing limits on unproven peptides